SC 13D/A:超过5%持股股东披露文件(修正)-Havencrest Healthcare Partners GP, LLC(0.33%),Havencrest Healthcare Partners, L.P.(0.13%)等
4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
4:持股变动声明-董事 Hively Brad
4:持股变动声明-董事 Hively Brad
4:持股变动声明-高管 Virnich Daniel
4:持股变动声明-高管 Shah Mihir
4:持股变动声明-高管 Podnos Yale
4:持股变动声明-高管 Castle Jeremy
The Oncology Institute | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
The Oncology Institute | SC 13D/A:超过5%持股股东披露文件(修正)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%)等
The Oncology Institute | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
The Oncology Institute | 4:持股变动声明-董事 BARASCH RICHARD A
The Oncology Institute | 4:持股变动声明-董事 Hively Brad
The Oncology Institute | 4:持股变动声明-董事 Johnson Karen Marie
The Oncology Institute | 4:持股变动声明-董事 Kaushal Mohit
The Oncology Institute | 4:持股变动声明-董事 Ling Gabriel
The Oncology Institute | 4:持股变动声明-董事 McGeorge Anne
The Oncology Institute | 4:持股变动声明-董事 O'Meara Maeve
暂无数据